Article
Clonazepam repurposing in ARID1B patients through conventional RCT and N-of-1 Trials - An experimental strategy for orphan disease development
2024-02-12
Abstract excerpt
<h4>Background: </h4> Clinical trials for rare disorders have unique challenges, due to low prevalence, patient phenotype variability, and high expectations. These challenges are highlighted by our study on clonazepam in ARID1B patients, a common cause of intellectual disability. Previous studies on Arid1b haploinsufficient mice showed positive effects of clonazepam on various cognitive aspects. <h4>Methods: </h4...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 0fc29e3c-d9c5-5f97-8ff1-426900559abd
- DOI
- 10.21203/rs.3.rs-3937179/v1
